Fast-tracking novel drugs in pediatric oncology-Reference-Cited by-同舟云学术

Fast-tracking novel drugs in pediatric oncology

Published:2015-04-18 Issue:8 Volume:14 Page:1127-1128
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Subbiah Vivek¹²

Affiliation:

1. Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program); Division of Cancer Medicine; The University of Texas MD Anderson Cancer Center; Houston, TX USA

2. Division of Pediatrics; The University of Texas MD Anderson Cancer Center; Houston, TX USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2015.1018049

Reference7 articles.

1. Remaining Challenges in Childhood Cancer and Newer Targeted Therapeutics

2. Challenging issues in pediatric oncology

3. Little patients, losing patience: pediatric cancer drug development

4. Theranostic profiling for actionable aberrations in advanced high risk osteosarcoma with aggressive biology reveals high molecular diversity: the human fingerprint hypothesis

5. Prospects and Pitfalls of Personalizing Therapies for Sarcomas: From Children, Adolescents, and Young Adults to the Elderly

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-of-1 Trials in Cancer Drug Development;Cancer Discovery;2023-04-18

2. The next generation of evidence-based medicine;Nature Medicine;2023-01

3. Exportin(g) precision oncology beyond genomics with XPO1 inhibition;Med;2022-11

4. Developing Novel Anticancer Drugs for Targeted Populations: An Update;Current Pharmaceutical Design;2021-02-04

5. Introduction: specific disease areas;Considering the Patient in Pediatric Drug Development;2021